文献速递消化内镜消化道肿瘤与早癌

早期食管鳞状上皮肿瘤沿导管及黏膜下腺延伸及其对消融治疗的影响

Extension of early esophageal squamous cell neoplasia into ducts and submucosal glands and the role of endoscopic ablation therapy.
PubMed 文献 · Gastrointest Endosc · 2021-05-08

研究评估早期食管鳞状上皮肿瘤(ESCN)沿导管及黏膜下腺(SMG)延伸的情况,并比较环形射频消融(c-RFA)、局灶射频消融(RFA)和冷冻球囊消融(CBA)对SMG的消融深度。ESCN在多数患者中延伸至导管/SMG,动物模型中局灶RFA和CBA可有效消融SMG,而c-RFA消融不充分。内镜切除仍应作为标准治疗。

要点

  • 多数ESCN患者存在肿瘤沿导管及黏膜下腺延伸。
  • c-RFA对SMG消融不充分,可能导致局部复发。
  • 局灶RFA和CBA在动物模型中可有效消融SMG。

核心结论

  • ESCN在多数患者中延伸至导管/SMG,c-RFA对SMG消融不充分,内镜切除仍应作为标准治疗。

研究设计与样本

  • 研究评估日本(n=65)和荷兰(n=14)队列的平坦型ESCN内镜黏膜下剥离标本中导管/SMG的肿瘤累及。
  • 动物实验预设生存期(0小时、8小时、2天、5天、28天)后评估消融均匀性、深度及SMG受累情况。

主要发现

  • 导管/SMG肿瘤延伸见于多数病变:日本队列58%(38/65),荷兰队列64%(9/14)。
  • c-RFA后33%的SMG(95%CI 28-50)未受累,尽管表面上皮已被消融。
  • 局灶RFA和CBA实现均匀消融,所有SMG均被有效治疗。

关键数值与推荐

  • c-RFA后未受累SMG比例为33%(95%CI 28-50)。

临床怎么用

  • 对于平坦型ESCN,应考虑肿瘤沿导管/SMG延伸的可能性。
  • 局灶RFA和CBA可能有效消融SMG,但c-RFA可能不充分。
  • 内镜切除应继续作为早期ESCN的标准治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Early esophageal squamous cell neoplasia (ESCN) is preferably treated with en-bloc endoscopic resection. Ablation might be an alternative for flat ESCN, but ESCN extension along the epithelial lining of ducts and submucosal glands (SMGs) might jeopardize ablation efficacy. Clinical studies suggest that local recurrence might arise from such buried ESCN niches after ablation. We studied human endoscopic resection specimens of ESCN to quantify ESCN extension into ducts/SMGs and performed a prospective porcine study to evaluate the depth of radiofrequency ablation (RFA) and CryoBalloon ablation (CBA) into ducts/SMGs. METHODS: Endoscopic submucosal dissection specimens of flat-type ESCN from a Japanese (n = 65) and Dutch cohort (n = 14) were evaluated for presence and neoplastic involvement of ducts/SMGs. Twenty-seven pigs were treated with circumferential RFA (c-RFA; n = 4), focal CBA (n = 20), and focal RFA (n = 3) with 4, 60, and 9 treatment areas, respectively. After prespecified survival periods (0 hours, 8 hours, 2 days, 5 days, and 28 days), treatment areas were evaluated for uniformity and depth of ablation and affected SMGs. RESULTS: Neoplastic extension in ducts/SMGs was observed in most lesions: 58% (38/65) in the Japanese and 64% (9/14) in the Dutch cohort. In the animal study, 33% of SMGs (95% confidence interval, 28-50) were not affected after c-RFA, although the overlying epithelium was ablated. Focal RFA and CBA resulted in uniform ablations with effective treatment of all SMGs. CONCLUSIONS: ESCN extends into ducts/SMGs in most patients. In an animal model, focal RFA and CBA effectively ablated SMGs, whereas c-RFA inadequately ablated SMGs. Given this potential reason for recurrence, endoscopic resection should remain the standard of care.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Overwater A, van Munster SN, Offerhaus GJA, et al. Extension of early esophageal squamous cell neoplasia into ducts and submucosal glands and the role of endoscopic ablation therapy. Gastrointest Endosc. 2021. PMID: 33974941. doi:10.1016/j.gie.2021.04.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。